Cite

HARVARD Citation

    Poyet, C. et al. (2015). Connexin 43 expression predicts poor progression-free survival in patients with non-muscle invasive urothelial bladder cancer. Journal of clinical pathology. 68 (10), pp. 819-824. [Online]. 
  
Back to record